Filter Results :

Your search for Therapies returned 69 reports

Sort by


Advanced Catheter Therapies Inc - Medical Equipment - Deals and Alliances Profile

06 Apr 2017  |  Published by:  GlobalData
SummaryAdvanced Catheter Therapies Inc (ACT) is a medical device company that offers novel catheter technologies targeting vascular disease such as inflammation, thrombosis, occlusions and restenosis. The company is developing a device for restenosis and catheters for endovascular debulking. It offe...

$ 250.00

Read More

Natural Killer Cells Therapies- Competitive Landscape,Technology and Pipeline Analysis, 2017

01 Apr 2017  |  Published by:  DelveInsight
“Natural Killer Cells Therapies- Competitive Landscape, Technology and Pipeline Analysis, 2017”, emphasizes on the currently active NK cell therapy products and NK cell augmenters in research and development.  The report covers 20+ companies, which are active in this field with 40+ products and...

$ 2,450.00

Read More

Antibacterial Therapies Drug Development Pipeline Review, 2017

22 Mar 2017  |  Published by:  GBI Research
SummaryThe antibacterial drug market covers the drugs used in the prophylaxis and treatment of bacterial infections. With a growing global concern over antimicrobial resistance and its progressive growth, there is a pronounced need for innovation within this market.There are over 1400 products in ac...

$ 3,995.00

Read More

Intra-Cellular Therapies Inc (ITCI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

20 Mar 2017  |  Published by:  GlobalData
SummaryIntra-Cellular Therapies Inc (ITI) is a biopharmaceutical company that concentrates on the discovery and development of small molecule drugs to treat neuropsychiatric and neurologic disorders. The company's lead product candidate, ITI-007, which is intended for the treatment of schizophrenia,...

$ 250.00

Read More

Biotie Therapies Corp (BTH1V) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

10 Mar 2017  |  Published by:  GlobalData
SummaryBiotie Therapies Corp (Biotie) is a pharmaceutical company that discovers and develops new medicines for the treatment of various diseases. The company offers products for use in the treatment of neurodegenerative and psychiatric disorders such as parkinson's disease, alzheimer's disease, pri...

$ 250.00

Read More

BioRestorative Therapies Inc (BRTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

10 Mar 2017  |  Published by:  GlobalData
SummaryBioRestorative Therapies Inc (BRT), formerly Stem Cell Assurance, Inc. is a biotechnology company that develops products and therapies using cell and tissue protocols. The company performs stem cell programs which include brtxDISC and ThermoStem. brtxDISC,a lead therapeutic product, is design...

$ 250.00

Read More

Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

09 Mar 2017  |  Published by:  GBI Research
SummaryNon-Small Cell Lung Cancer (NSCLC) is the most common cancer and the leading cause of cancer-related mortality globally. There were more than 1.8 million newly diagnosed lung cancer cases in 2012, accounting for 13% of the total number of cancer cases. This figure has been gradually rising wi...

$ 4,995.00

Read More

Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market

01 Mar 2017  |  Published by:  GBI Research
SummaryThe respiratory therapy area consists of indications that affect the respiratory system in various ways, including the scarring of lung tissue and excessive production of mucus in the airways, thereby decreasing lung function. The causes of respiratory disorders vary significantly between ind...

$ 4,995.00

Read More

Frontier Pharma: Head and Neck Cancer - Immunotherapies and Signal Transduction Inhibitors Dominate First-in-Class Innovation

01 Mar 2017  |  Published by:  GBI Research
SummaryHead and neck squamous cell carcinoma is the sixth most common cancer, and its incidence is rising. The term head and neck cancer (HNC) comprises a number of malignancies that usually begin in the squamous cells that line the moist, mucosal surfaces inside the head and neck. These cancers dev...

$ 6,995.00

Read More

Prostate Cancer - Newer Antiandrogens & Emerging Therapies Targeting a 'Watchful Waiting' and Resistance Population

01 Feb 2017  |  Published by:  MP Advisors
This report details current unmet need, changing regulatory requirement, reimbursement challenges & market dynamics of Prostate Cancer drugs.  Report mention pipeline Antiandrogens, late stage prostate cancer pipeline drugs/new Mechanism of action & major companies developing Prostate c...

$ 4,500.00

Read More

Vital Therapies Inc (VTL) - Medical Equipment - Deals and Alliances Profile

25 Jan 2017  |  Published by:  GlobalData
SummaryVital Therapies Inc (Vital Therapies) is a bio therapeutic company that develops cell-based therapy treatment for liver failure. The company’s clinical trials include VTI-206, VTI-208, VTI-210, VTI-201, VTIC-301, and VTI-212. Its product ELAD is a human cell based liver support system designe...

$ 250.00

Read More

Breakthrough Therapies: Market Dynamics and Investment Opportunities

24 Jan 2017  |  Published by:  BCC Research-JT Gabrielsen Consulting LLC Research
The global market for breakthrough therapy designation drugs should reach $99.2 billion by 2022 from $48.8 billion in 2017 at a compound annual growth rate (CAGR) of 15.2%, from 2017 to 2022.Report Includes-An overview of the global markets for breakthrough therapies, their dynamics, and investment ...

$ 6,650.00

Read More

Vital Therapies Inc (VTL) - Financial and Strategic SWOT Analysis Review

13 Jan 2017  |  Published by:  GlobalData
SummaryVital Therapies Inc (Vital Therapies) is a bio therapeutic company that develops cell-based therapy treatment for liver failure. The company’s clinical trials include VTI-206, VTI-208, VTI-210, VTI-201, VTIC-301, and VTI-212. Its product ELAD is a human cell based liver support system designe...

$ 300.00

Read More

Seasonal Influenza Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Elderly Population, Growing Awareness and Launch of Quadrivalent Therapies

02 Jan 2017  |  Published by:  GBI Research
SummaryInfluenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses, designated as influenza Type A, B, and C. The infection’s rapid onset and potential for high morbidity and mortality, particularly in high-risk patient populations such as the el...

$ 4,995.00

Read More

COPD Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies

01 Jan 2017  |  Published by:  GBI Research
SummaryChronic obstructive pulmonary disease (COPD) is a term that refers to a large group of lung diseases characterized by obstruction of air flow that interferes with normal breathing. COPD occurs most often in older people, but can also affect people in their middle ages. It is a major cause of ...

$ 4,995.00

Read More
Total 69 records.